D.E. Shaw & Co’s CareDx CDNA Stock Holding History

D.E. Shaw & Co’s Portfolio CDNA Stock Details CDNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-12,900	Closed	-$324K	–	3617
2018 Q4	$324K	Buy	+12,900	New	+$331K	﹤0.01%	3305

Other funds holding CDNA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return

Chevy Chase Trust Bethesda, Maryland $34.7B AUM 29.45% 1-Year Est. Return

D.E. Shaw & Co's CDNA Position: Q1 2026 in Review

D.E. Shaw & Co reduced its CareDx (CDNA) stake by 16% in Q1 2026, selling an estimated $3.1M and leaving 874,908 shares worth $15.2M. The position accounts for 0.01% of the portfolio, ranked #1331.

D.E. Shaw & Co first reported a position in CDNA in Q2 2018 and has held it in 32 quarters since. The position peaked at $89M in Q4 2020. 190 funds tracked by Wall St. Rank hold CDNA as of Q1 2026.

D.E. Shaw & Co held 874,908 shares of CareDx worth $15.2M as of Q1 2026.
D.E. Shaw & Co sold 163,578 CareDx shares in Q1 2026, an estimated $3.1M.
CareDx made up 0.01% of D.E. Shaw & Co's portfolio in Q1 2026, its #1331 holding.
D.E. Shaw & Co first reported a position in CareDx in Q2 2018 and has held it in 32 quarters since.
D.E. Shaw & Co's CareDx position peaked at $89M in Q4 2020.
190 funds tracked by Wall St. Rank held CareDx as of Q1 2026.

Based on D.E. Shaw & Co's 13F filing for Q1 2026, filed 15 May 2026.